Company Email Format

Verseau Therapeutics

Biotechnology Research Bedford, Massachusetts, United States 6 employees

Employees: 6
Contacts: 1
Emails: 1
Phones: 1

verseautx.com LinkedIn Crunchbase

Verseau Therapeutics Overview

Headquarters: Bedford, Massachusetts, United States
Website: verseautx.com
Industry: Biotechnology Research
Employees: 6
Founded: 2017
Funding: 50.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Verseau Therapeutics

Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors. This is accomplished by stimulating macrophages to shift their phenotype from immunosuppressive to a pro-inflammatory, anti-tumor state in a process called macrophage repolarization. Verseau developed a unique target discovery engine that leveraged patient data and computational biology to discover and validate over 20 novel macrophage targets. Verseau’s first-in-class monoclonal antibody candidates, VTX-0811 targeting PSGL-1 and VTX-1218 targeting VSIG4, are in late preclinical development and progressing toward clinical trials.

Verseau Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

Verseau Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Hillel Bachrach	Managing Partner at 20/20 Healthcare Partners	Auburndale, Massachusetts, United States	Email Phone
Anna Turetsky	Biotech Venture Capital Investing & Strategy	New York, United States	View
Tatiana Novobrantseva	Inventing and Developing New Medicines, Building Teams.	Greater Boston, United States	View